E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research 


The efficacy and safety of methotrexate and intermittent cyclosporine therapy in extensive chronic plaque psoriasis: A randomized, double-blind, and comparative study

Suchibrata Das, Sangita Patra, Saikat Banerjee, Alok Kumar Roy.

Abstract
Background: Psoriasis vulgaris is common papulosquamous disorder. Methotrexate (MTX) and cyclosporine, both of these drugs are in regular use for psoriasis management. But which one is superior in efficacy are yet to establish.

Aims and Objectives: The aim of the study was to compare efficacy of MTX and intermittent cyclosporine therapy in the management of extensive/severe psoriasis, and to find and compare the incidence of adverse effects/safety of both the drugs.

Materials and Methods: A randomized and controlled study was designed to compare the efficacy and safety of treatment. Patients with extensive psoriasis were randomly put in two groups –MTX and cyclosporine group and treated for 12 weeks.

Results: Psoriasis area severity index (PASI) gradually reduced in both group, that is, up to second visit of study, (4 Weeks after induction of study) the reduction was at par. After that, it reduced in Cyclosporine group significantly faster than MTX group. At the end of the study, that is, after 12 weeks, the difference of PASI in both groups was not significant.
Side-effects were not serious and minimal.

Conclusion: Both the drugs are effective, but Cyclosporine is faster in onset than MTX. Adverse effects are nominal and not serious.

Key words: Psoriasis; Methotrexate; Intermittent Cyclosporine; Efficacy; Adverse Effects


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Suchibrata Das
Articles by Sangita Patra
Articles by Saikat Banerjee
Articles by Alok Kumar Roy
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Das S, Patra S, Banerjee S, Roy AK. The efficacy and safety of methotrexate and intermittent cyclosporine therapy in extensive chronic plaque psoriasis: A randomized, double-blind, and comparative study. Natl J Physiol Pharm Pharmacol. 2023; 13(12): 2433-2439. doi:10.5455/njppp.2023.13.04171202312052023


Web Style

Das S, Patra S, Banerjee S, Roy AK. The efficacy and safety of methotrexate and intermittent cyclosporine therapy in extensive chronic plaque psoriasis: A randomized, double-blind, and comparative study. https://www.njppp.com/?mno=148286 [Access: February 01, 2024]. doi:10.5455/njppp.2023.13.04171202312052023


AMA (American Medical Association) Style

Das S, Patra S, Banerjee S, Roy AK. The efficacy and safety of methotrexate and intermittent cyclosporine therapy in extensive chronic plaque psoriasis: A randomized, double-blind, and comparative study. Natl J Physiol Pharm Pharmacol. 2023; 13(12): 2433-2439. doi:10.5455/njppp.2023.13.04171202312052023



Vancouver/ICMJE Style

Das S, Patra S, Banerjee S, Roy AK. The efficacy and safety of methotrexate and intermittent cyclosporine therapy in extensive chronic plaque psoriasis: A randomized, double-blind, and comparative study. Natl J Physiol Pharm Pharmacol. (2023), [cited February 01, 2024]; 13(12): 2433-2439. doi:10.5455/njppp.2023.13.04171202312052023



Harvard Style

Das, S., Patra, . S., Banerjee, . S. & Roy, . A. K. (2023) The efficacy and safety of methotrexate and intermittent cyclosporine therapy in extensive chronic plaque psoriasis: A randomized, double-blind, and comparative study. Natl J Physiol Pharm Pharmacol, 13 (12), 2433-2439. doi:10.5455/njppp.2023.13.04171202312052023



Turabian Style

Das, Suchibrata, Sangita Patra, Saikat Banerjee, and Alok Kumar Roy. 2023. The efficacy and safety of methotrexate and intermittent cyclosporine therapy in extensive chronic plaque psoriasis: A randomized, double-blind, and comparative study. National Journal of Physiology, Pharmacy and Pharmacology, 13 (12), 2433-2439. doi:10.5455/njppp.2023.13.04171202312052023



Chicago Style

Das, Suchibrata, Sangita Patra, Saikat Banerjee, and Alok Kumar Roy. "The efficacy and safety of methotrexate and intermittent cyclosporine therapy in extensive chronic plaque psoriasis: A randomized, double-blind, and comparative study." National Journal of Physiology, Pharmacy and Pharmacology 13 (2023), 2433-2439. doi:10.5455/njppp.2023.13.04171202312052023



MLA (The Modern Language Association) Style

Das, Suchibrata, Sangita Patra, Saikat Banerjee, and Alok Kumar Roy. "The efficacy and safety of methotrexate and intermittent cyclosporine therapy in extensive chronic plaque psoriasis: A randomized, double-blind, and comparative study." National Journal of Physiology, Pharmacy and Pharmacology 13.12 (2023), 2433-2439. Print. doi:10.5455/njppp.2023.13.04171202312052023



APA (American Psychological Association) Style

Das, S., Patra, . S., Banerjee, . S. & Roy, . A. K. (2023) The efficacy and safety of methotrexate and intermittent cyclosporine therapy in extensive chronic plaque psoriasis: A randomized, double-blind, and comparative study. National Journal of Physiology, Pharmacy and Pharmacology, 13 (12), 2433-2439. doi:10.5455/njppp.2023.13.04171202312052023